SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Worth every minute - SQI Investor Presentation

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Mar 01, 2021 11:02am

138 Views

Post# 32685147

RE:Worth every minute - SQI Investor Presentation

Personally, I like Page 5.

Adds up to $ 2.2 Billion !!! (likely understated when home diagnostics, for many, many conditions, explodes in the future)

Having a hard time finding another Company that would be able to compete on the basis of :

sufficiently developed IP (20 years in the making)
accuracy of testing (>99%)
efficiency of testing (multiple samples, 1-2 drops)
proximity to FDA approval (EAU) Q2
relevence of their tests to the "next phase" of this pandemic (i.e.immunity/antibodies going forward, etc.) - not whether you have Covid-19.

MM

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?